Cyclerion Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.36

-0.03 (-0.74%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +548.9% upside

Low Target $14.42

Average Target $21.77

High Target $30.48

Current Price $3.36

Current
$3.36

Target
$21.77

$14.42 $21.77 avg $30.48

Scenario Analysis

Bear Case

$14.42

329.8%

Low target

Base Case

$21.77

+548.9%

Avg target

Bull Case

$30.48

+808.5%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$8.48

-60.4% from high

52-Week Low

$1.03

+226.8% from low

Target vs 52W High

$21.77

+156.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%